A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator. (2019)

First Author: Athukoralage JS
Attributed to:  Cyclic oligoadenylate signalling - a new type of antiviral response funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jmb.2019.04.041

PubMed Identifier: 31071326

Publication URI: http://europepmc.org/abstract/MED/31071326

Type: Journal Article/Review

Volume: 431

Parent Publication: Journal of molecular biology

Issue: 15

ISSN: 0022-2836